Clinically proven

With Opt-IVF, every patient gets a plan as unique as they are, powered by an intelligent algorithm. Designed to decrease gonadotrophin dose while dramatically improving clinical outcomes.

Request demo Learn more

Opt-IVF is a physician-only decision support tool that uses patient-specific data to predict the optimal drug dosage during the ovarian stimulation phase of IVF. The software supports both GnRH agonist and antagonist protocols and eliminates the need for daily hormone testing. Ultrasounds are only required on days 1 and 5, helping streamline the clinical workflow.

Yes. Opt-IVF is grounded in rigorous scientific research and validated through four clinical trials and a cohort study. In practice, clinics using Opt-IVF have reported up to a 32% reduction in hormone usage without compromising outcomes.

As one physician noted,“Opt-IVF has enabled us to significantly reduce hormonal dosages while achieving a higher number of Grade A embryos… [with] noticeably higher pregnancy rates.”

Quite the opposite. Clinical data and real-world use consistently show improved outcomes with lower doses when guided by Opt-IVF.

As one provider shared, “The results were impressive across all key metrics: a 30% reduction in hormone dosage, a greater number of Grade A embryos, and a substantial increase in pregnancy rates.”

Opt-IVF offers a more efficient, evidence-based approach tailored to each patient. Clinics have seen meaningful improvements in embryo quality and pregnancy rates, while also reducing medication costs and monitoring burden.

As one physician put it, “We intend to continue using the Opt-IVF software for its significantly better outcomes in terms of improved oocyte and embryo quality.”